Neha Mehta-Shah, MD, MSCI, on Bispecific Antibodies in B-cell Lymphomas, at ASH 2022

By Cecilia Brown, Neha Mehta-Shah, MD, MSCI - Last Updated: January 10, 2023

Neha Mehta-Shah, MD, MSCI, of Washington University School of Medicine in St. Louis, discusses treatment advances in lymphoma, a paradigm shift she’s seen in mantle cell lymphoma, why she is excited about bispecific antibodies in B-cell lymphoma, her hopes for the future, and more, during the 2022 American Society of Hematology Annual Meeting.

Advertisement

Post Tags:Lymphoma ASH 22
Advertisement
Advertisement
Advertisement
Editorial Board